resources

Investigation of subcutaneous monoclonal antibody formulations

Investigation of subcutaneous monoclonal antibody formulations

Applications Note

Preview - This content has been restricted to logged in users only.

There is a strong patient preference for subcutaneous (SC) delivery of parenteral drugs. SC therapies are safer to administer and less time-consuming than intravenous (IV) therapies
Investigation of subcutaneous monoclonal antibody formulations

Applications Note

There is a strong patient preference for subcutaneous (SC) delivery of parenteral drugs. SC therapies are safer to administer and less time-consuming than intravenous (IV) therapies and they do not require supervision by medical professionals, making them suitable for self-managed home care treatments.

Previous post